Axogen, Inc. Is A Biotechnology Company Based In Alachua, Florida, Focused On Surgical Solutions For Peripheral Nerve Regeneration And Repair. Founded In 2002, Axogen Emerged From Nerve Repair Technology Developed At The University Of Florida And The University Of Texas At Austin. The Company Is Recognized As A Market Leader In Nerve Repair, Offering Clinically Proven Products That Aim To Restore Peripheral Nerve Function And Enhance Patients' Quality Of Life. Axogen Provides A Comprehensive Portfolio Of Nerve Repair Products, Including The Avance Nerve Graft, Axoguard Nerve Connector, And Axoguard Nerve Protector. These Products Are Designed To Address Nerve Damage From Trauma Or Surgical Procedures And Are Supported By FDA Approvals. The Company Primarily Serves Surgeons And Healthcare Providers In Specialties Such As Plastic Surgery, Orthopedics, And Neurosurgery, Offering Education And Training To Improve Treatment Methods. With A Strong Focus On Research And Development, Axogen Continues To Expand Its Product Offerings And Maintain Its Leadership In The Regenerative Medicine Market.